Healthcare / Health Information ServicesStockholm
$7.68
-0.20 (-2.57%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-773782.00 · quality 49.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
14/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$125M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-33.7%
↓Gross Margin
100.0%
↑Debt/Equity
0.25
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2024 · 2 años de histórico normalizado
Revenue CAGR
+13.7%
FCF CAGR
—
FCF margin
-2.2%
FCF / Net income
0.06x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $16.2M · net income $-6.5M · FCF $-363543.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $16.2M | $16.2M | $14.7M | $12.5M |
| Net Income | $-6.5M | $-6.5M | $2.8M | $92319.00 |
| EBITDA | $-2.1M | $-2.1M | $6.7M | $2.6M |
| EPS | -0.40 | -0.40 | 0.17 | 0.01 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -12.4% | -12.4% | -6.4% | -3.1% |
| Net Margin | -39.9% | -39.9% | 19.1% | 0.7% |
| Balance Sheet | ||||
| Debt/Equity | 0.25 | 0.25 | 0.14 | 0.04 |
| Current Ratio | 0.44 | 0.44 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $-363543.00 | $-363543.00 | $-773782.00 | $-3.0M |
| Returns | ||||
| ROE | -33.7% | -33.7% | 11.2% | 0.4% |
| Valuation | ||||
| P/E | — | — | 95.88 | 2340.00 |
| EV/EBITDA | — | — | 40.28 | 148.05 |
| P/B | 6.52 | 6.52 | 10.55 | 17.06 |
| Growth & Yield | ||||
| Revenue Growth | 9.7% | 9.7% | 17.9% | — |
| EPS Growth | -335.3% | -335.3% | 1600.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-37.4%
Start / end P/E
n/dx → n/dx
EPS bridge
0.17 → -0.40
Residual
-37.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.